國家衛生研究院 NHRI:Item 3990099045/10304
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907611      Online Users : 968
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10304


    Title: Statins protect airway epithelium against bacterial pore-forming toxins
    Authors: Kao, CY;Hung, LY;Ruan, JW;Chang, CY;Lim, JH;Li, JD;Wu, R
    Contributors: Immunology Research Center
    Abstract: Infectious diseases remain a leading cause of morbidity and mortality worldwide. Antibiotics are used to treat many common forms of bacterial infections. However, the discovery of new classes of antibiotics has lagged behind in the last several decades, and yet the emergence of multi-drug resistant bacterial strains due to the widespread overuse of antibiotics is a growing problem. There is a critical need for antibacterial agents not subject to currently observed resistance mechanisms. Pneumonia kills approximately two million children each year worldwide and millions of people get pneumonia annually in the United States alone. Airway epithelia are the initial and primary sites of many bacterial contacts and their barrier and immunity functions are critical to fight infections. Using primary normal human bronchial epithelial (NHBE) cells and an immortalized normal bronchial epithelial cell line, HBE1, here we show that the prior exposure to statins confers significant cellular resistance to the cytotoxicity of pneumolysin and -hemolysin. Pneumolysin and -hemolysin are the main pore-forming toxins, the single largest class of bacterial virulence factors, shown to play critical roles in bacterial pathogenesis respectively in Streptococcus and , two common causes of bacterial infections. We further found that the protection requires protein pneumoniae Staphylococcus aureus synthesis and is calcium dependent. With siRNA gene silencing, pharmacological inhibitors, immuno fluorescence microscopy and biochemical approaches, we have delineated the statin-mediated cellular protection mechanisms in airway epithelial cells. Our animal experiment results further suggest that statin pre-treatment could reduce the lung inflammation caused by pneumolysin. The ultimate goal of this study is to elucidate the interactions of pore-forming toxins and the host cells at the molecular level and this might be potentially developed as a novel host-directed adjuvant therapy in pore-forming toxin-related bacterial infections.
    Date: 2013-05-19
    Relation: American Journal of Respiratory and Critical Care Medicine. 2013 May 19;187:Meeting Abstract A6095.
    Link to: http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A6095
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1073-449X&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000209838403085
    Appears in Collections:[Others] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    ISI000209838403085.pdf16KbAdobe PDF383View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback